X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (614) 614
Publication (119) 119
Paper (8) 8
Book Review (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (435) 435
humans (371) 371
female (268) 268
male (252) 252
cardiac & cardiovascular systems (233) 233
aged (227) 227
heart failure (190) 190
mortality (190) 190
cardiovascular (183) 183
middle aged (180) 180
abridged index medicus (158) 158
aged, 80 and over (97) 97
patients (91) 91
risk factors (85) 85
cardiac patients (82) 82
hospitalization (80) 80
retrospective studies (76) 76
article (75) 75
treatment outcome (75) 75
adult (74) 74
outcomes (74) 74
united states - epidemiology (72) 72
analysis (70) 70
hospitals (68) 68
heart attacks (67) 67
drug therapy (64) 64
heart failure - therapy (64) 64
heart failure - mortality (63) 63
registries (62) 62
medical colleges (61) 61
risk (58) 58
medical research (56) 56
clinical trials (55) 55
management (55) 55
care and treatment (53) 53
prognosis (52) 52
medicine, experimental (51) 51
cardiovascular disease (50) 50
medicare (48) 48
studies (47) 47
united states (47) 47
follow-up studies (46) 46
patient outcomes (46) 46
association (45) 45
heart failure - physiopathology (45) 45
acute disease (44) 44
heart failure - drug therapy (44) 44
research (44) 44
stroke (43) 43
disease (42) 42
guidelines (42) 42
internal medicine (40) 40
time factors (39) 39
cardiology (38) 38
heart (38) 38
risk assessment (38) 38
diagnosis (37) 37
epidemiology (37) 37
cohort studies (36) 36
medicine, general & internal (36) 36
health aspects (35) 35
diabetes (34) 34
prevalence (33) 33
animals (32) 32
heart diseases (32) 32
therapy (32) 32
cardiology and cardiovascular medicine (31) 31
cell biology (31) 31
prospective studies (31) 31
survival (31) 31
age (30) 30
cancer (29) 29
research article (29) 29
cardiovascular diseases (28) 28
trends (28) 28
hospital mortality (27) 27
surgery (27) 27
survival rate - trends (27) 27
double-blind method (26) 26
multidisciplinary sciences (26) 26
prevention (26) 26
care (25) 25
confidence intervals (25) 25
health risk assessment (25) 25
hypertension (25) 25
impact (25) 25
medicine (25) 25
multivariate analysis (25) 25
practice guidelines as topic (25) 25
heart failure - complications (24) 24
heart failure - diagnosis (24) 24
heart failure - epidemiology (24) 24
medical care (23) 23
randomized controlled trials as topic (23) 23
registry (23) 23
acute myocardial-infarction (22) 22
atrial fibrillation (22) 22
biochemistry & molecular biology (22) 22
disease progression (22) 22
quality management (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2012, Volume 144, Issue 3, pp. e29 - e84
Journal Article
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2015, Volume 21, Issue 6, pp. 519 - 534
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 06/2016, Volume 117, Issue 11, pp. 1771 - 1778
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 6, pp. 957 - 970
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 103 - 110
Exenatide once-weekly is an extended release formulation of exenatide, a glucagon-like peptide–1 receptor agonist, which can improve glycemic control, body... 
Cardiovascular | DIABETES-MELLITUS | HEART | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | PIOGLITAZONE | GLUCAGON-LIKE PEPTIDE-1 | SAFETY | RECEPTOR AGONISTS | GLUCOSE | CLINICAL-TRIALS | DISEASE | Risk Assessment - methods | United States - epidemiology | Glucagon-Like Peptide 1 | Prognosis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Peptides - administration & dosage | Incidence | Dose-Response Relationship, Drug | Microspheres | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Cardiovascular Diseases - etiology | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Factors | China - epidemiology | Diabetes Mellitus, Type 2 - blood | Ontario - epidemiology | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Hypoglycemic agents | Glucagon | Cardiac patients | Heart attack | Corporate sponsorship | Heart attacks | Research & development--R&D | Pragmatism | Cardiovascular disease | Diabetes | Pharmaceutical industry | Patients | Cholesterol
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 6, pp. 846 - 852.e2
Journal Article